Suvoda Executive and Leadership Team

Jagath Wanninayake, the Chief Executive Officer at Suvoda, directs the overarching corporate strategy and long-term vision for the organization. By prioritizing the development of innovative Interactive Response Technology, the Chief Executive Officer ensures that clinical trials maintain high standards of patient safety and operational efficiency. Wanninayake oversees the alignment of global teams to support complex study designs for biopharmaceutical clients. This leadership role involves constant engagement with the Board to drive sustainable growth and market expansion. Through the implementation of scalable SaaS solutions, the Chief Executive Officer maintains the company's competitive edge in the health software sector. By fostering a culture of technical excellence, Wanninayake empowers the entire organization to solve intricate supply chain challenges. Ultimately, the Chief Executive Officer secures the company's position as a leader in clinical trial technology.

Brian Greenfield, the Chief Financial Officer at Suvoda, manages the financial health and capital allocation strategies for the organization. Overseeing fiscal planning and reporting, the Chief Financial Officer ensures that the company maintains the resources necessary to invest in innovative clinical trial technology. Greenfield directs the financial analysis required to support global expansion and long-term growth initiatives. This leadership role involves working closely with the executive team to evaluate investment opportunities and manage operational budgets. By maintaining rigorous financial controls, Brian Greenfield provides the stability needed to support the company's mission of transforming clinical research. Through the oversight of financial performance, the Chief Financial Officer enables the organization to navigate the complexities of the health software market. Greenfield ensures that all financial activities align with the company's strategic objectives and commitment to delivering value to customers.

John Samar, the Chief Financial Officer & Founder at Suvoda, focuses on the long-term financial sustainability and foundational growth of the company. Overseeing the strategic financial architecture, the Chief Financial Officer & Founder ensures that the organization remains well-positioned to innovate within the clinical trial space. Samar manages the capital structure and investor relations to support the ongoing development of the Interactive Response Technology platform. This leadership role involves identifying new market opportunities and assessing the financial viability of long-term product roadmaps. By leveraging deep industry knowledge, John Samar provides the guidance necessary to maintain the company's competitive advantage. Through the management of financial risk and resource allocation, the Chief Financial Officer & Founder supports the company's ability to serve biopharmaceutical clients of all sizes. Samar ensures that the company's foundational values remain integrated into every financial decision.

Jp Samar, the Chief Financial Officer & Founder at Suvoda, directs the corporate development and financial planning functions to ensure the company's continued market impact. Overseeing the integration of financial strategy with product innovation, the Chief Financial Officer & Founder ensures that the company's SaaS offerings remain financially viable and scalable. Samar manages the fiscal oversight of global operations, ensuring that resources are directed toward high-impact areas of clinical trial support. This leadership role involves collaborating with the executive team to refine the company's business model and expand its reach in the biopharmaceutical sector. By monitoring market trends, Jp Samar provides the strategic insight needed to navigate the complexities of the health software industry. Through the management of financial performance, the Chief Financial Officer & Founder supports the company's mission to solve complex supply chain challenges. Samar maintains a focus on long-term value creation.

Robert Hummel, the Chief Operating Officer at Suvoda, directs the internal scaling and infrastructure required to support global clinical trial operations. Overseeing the delivery of Interactive Response Technology, the Chief Operating Officer ensures that the company's SaaS platform meets the rigorous demands of complex study designs. Hummel manages the operational workflows that allow the organization to provide exceptional customer and advisory services to biopharmaceutical clients. This leadership role involves optimizing internal systems to enhance service reliability and project turnaround times. By driving efficiency across all operational departments, Robert Hummel supports the company's ability to handle large-scale, multi-site clinical trials. Through the implementation of robust processes, the Chief Operating Officer maintains high standards of quality control. Hummel ensures that the company's operational capacity aligns with the evolving needs of the global research community.

Yuko Fukasaku, the President, Suvoda (Japan) at Suvoda, directs all regional operations and business development initiatives within the Japanese market. Overseeing the implementation of Interactive Response Technology for local biopharmaceutical companies, the President, Suvoda (Japan) ensures that the company's solutions meet the specific regulatory and operational requirements of the region. Fukasaku manages the local team to provide exceptional customer and advisory services, supporting the company's global mission of clinical trial success. This leadership role involves building strong relationships with local research organizations to drive adoption of the company's SaaS platform. By analyzing regional market dynamics, Yuko Fukasaku optimizes the company's approach to solving complex patient randomization challenges in Japan. Through the management of regional growth, the President, Suvoda (Japan) ensures that the company's global standards are maintained while addressing the unique needs of the local market. Fukasaku drives the company's expansion in this critical territory.

Elena Filimonova, the Chief Marketing Officer at Suvoda, architects the global brand strategy and market positioning for the company's clinical trial software. Overseeing demand generation and corporate communications, the Chief Marketing Officer ensures that the value proposition of the Interactive Response Technology reaches biopharmaceutical companies and research organizations worldwide. Filimonova drives initiatives to increase market awareness across North American and international territories. This leadership role involves close collaboration with product teams to translate complex technical features into compelling market narratives. By analyzing industry trends and customer feedback, Elena Filimonova optimizes the company's outreach efforts to support sustained revenue growth. Through strategic content development and digital engagement, the Chief Marketing Officer strengthens the brand's reputation as a trusted partner in clinical research. Filimonova consistently elevates the company's visibility within the competitive health software landscape.

Kelly Snow, the Chief of Staff at Suvoda, manages internal operations and facilitates cross-functional alignment across the executive leadership team. Overseeing the execution of strategic priorities, the Chief of Staff ensures that organizational goals remain synchronized with the company's mission to transform clinical trials. Snow coordinates high-level projects that span multiple departments, from product development to customer advisory services. This leadership role involves streamlining communication channels to improve operational agility and decision-making speed. By monitoring key performance indicators, Kelly Snow provides the necessary oversight to maintain focus on critical business outcomes. Through the management of internal processes, the Chief of Staff supports the company's ability to scale effectively in a global market. Snow maintains a clear view of the operational landscape, ensuring that all teams contribute to the successful delivery of the company's SaaS solutions.

Andrew Prangle, the Account Executive & Chief Revenue Officer, Partnerships at Suvoda, directs the revenue generation strategy through the cultivation of strategic alliances. Overseeing the partnership ecosystem, the Account Executive & Chief Revenue Officer, Partnerships ensures that the company's Interactive Response Technology is integrated into the workflows of major clinical research organizations. Prangle manages the relationships that drive market penetration and customer acquisition across diverse geographic regions. This leadership role involves aligning partnership goals with the company's overall revenue targets to support sustained growth. By identifying and securing key collaborations, Andrew Prangle expands the company's footprint in the global biopharmaceutical market. Through the management of complex sales cycles, the Account Executive & Chief Revenue Officer, Partnerships ensures that the company delivers consistent value to its partners. Prangle drives the revenue initiatives that support the company's mission of transforming clinical trials.